Intellia Therapeutics (NTLA) PT Lowered to $45 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Greg Harrison lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $45.00 (from $50.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
